Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
ASPC Self-Assessment Program in Preventive Cardiology / / edited by Nathan D. Wong, Ezra A. Amsterdam, Peter P. Toth
| ASPC Self-Assessment Program in Preventive Cardiology / / edited by Nathan D. Wong, Ezra A. Amsterdam, Peter P. Toth |
| Autore | Wong Nathan D |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Humana, , 2024 |
| Descrizione fisica | 1 online resource (269 pages) |
| Disciplina | 616.105 |
| Altri autori (Persone) |
AmsterdamEzra A
TothPeter P |
| Collana | Contemporary Cardiology |
| Soggetto topico |
Cardiology
Internal medicine Internal Medicine |
| ISBN |
9783031562389
3031562380 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1 National and Global Trends of Cardiovascular Disease Mortality, Morbidity, and Risk -- Chapter 2 Cardiovascular Risk Assessment: From Global Risk Scoring to Risk Enhancing Factors -- Chapter 3 Assessment and Management of Psychosocial Risk Factors Within Preventive Cardiology Practice -- Chapter 4 Dietary Strategies for Atherosclerotic Cardiovascular Risk Reduction -- Chapter 5 Physical Activity Strategies -- Chapter 6 Obesity Management and Prevention of Cardiovascular Disease -- Chapter 7 Smoking and Vaping -- Chapter 8 Alcohol and Cardiovascular Diseases -- Chapter 9 The 2018 AHA/ACC/Multisociety Cholesterol Guidelines: A Personalized Approach to Risk Reduction -- Chapter 10 Blood Pressure and Hypertension Management -- Chapter 11 Cardiodiabetology Reducing Risks to Optimize -- Chapter 12 Cardiovascular Disease Outcomes -- Chapter 13 Antiplatelet Therapy -- Chapter 14 Inflammation and Atherosclerotic Cardiovascular Disease -- Chapter 15 The Role of Genetics in Preventive Cardiology: Utility of Clinically Available Genetic Tests -- Chapter 16 Exercise Electrocardiographic Stress Testing -- Chapter 17 Ultrasound and MRI Assessment of Cardiovascular Risk -- Chapter 18 Role of CT Coronary Calcium Scanning and Angiography in Evaluation of Cardiovascular Risk -- Chapter 19 Cardiovascular Disease Prevention in Women -- Chapter 20 Racial/Ethnic Considerations in the Prevention of Cardiovascular Disease -- Chapter 21 Prevention of Heart Failure -- Chapter 22 Prevention of Peripheral Arterial Disease -- Chapter 23 Prevention of Atrial Fibrillation -- Chapter 24 Prevention of Ischemic Stroke -- Chapter 25 Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease -- Chapter 26 Primary Prevention of Cardiovascular Disease Guidelines -- Chapter 27 Secondary Prevention and Cardiac Rehabilitation -- Chapter 28 Integrative Approaches for Cardiovascular Disease Prevention -- Chapter 29 Lipoprotein -- Chapter 30 Safety of Ultra-Low Low-density Lipoprotein Cholesterol -- Chapter 31 COVID-19 Infection and Cardiovascular Complications -- Chapter 32 Insulin Resistance -- Chapter 33 Epicardial Steatosis -- Chapter 34 Endothelial Cell Dysfunction. |
| Record Nr. | UNINA-9910920443703321 |
Wong Nathan D
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Humana, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Comprehensive Cardiovascular Medicine in the Primary Care Setting / / edited by Peter P. Toth, Christopher P. Cannon
| Comprehensive Cardiovascular Medicine in the Primary Care Setting / / edited by Peter P. Toth, Christopher P. Cannon |
| Edizione | [2nd ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Humana, , 2019 |
| Descrizione fisica | 1 online resource (XV, 536 p. 145 illus., 87 illus. in color.) |
| Disciplina | 616.1 |
| Collana | Contemporary Cardiology |
| Soggetto topico |
Primary care (Medicine)
Cardiology Primary Care Medicine |
| ISBN | 3-319-97622-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I: Cardiovascular Risk Factors -- Epidemiologic Characterization of Risk for Cardiovascular Disease -- Risk Quantitation: 10-year and Lifetime Estimation -- Hypertension -- Dyslipidemia -- Obesity and Therapeutic Approaches to Weight Loss -- Inflammatory Markers and Novel Risk Factors -- Deciphering Cardiovascular Genomics and How They Apply to Cardiovascular Disease Prevention -- Metabolic Syndrome -- Type I Diabetes Mellitus -- Type 2 Diabetes Mellitus -- Chronic Kidney Disease -- Part II: Coronary Artery Disease -- Evaluation of Chest Pain and Myocardial Ischemia -- Unstable Angina and NSTEMI -- ST Segment Elevated Myocardial Infarction -- Coronary Artery Stenting -- Coronary Artery Bypass Grafting -- Cardiac Rehabilitation. -Part III: Peripheral Forms of Venous and Arterial Disease -- Carotid Artery Disease -- Peripheral Arterial Disease -- Deep Venous Thrombosis and Pulmonary Embolism -- Pulmonary Hypertension and Cor Pulmonale -- Management of Ischemic Cerebrovascular Accident -- Aortic Aneurysms -- Erectile Dysfunction -- Part IV: Cardiac Disease -- Cardiac Valvular Disease -- Pericardial Diseases -- Common Atrial and Ventricular Arrhythmias -- Congestive Heart Failure -- Part V: Cardiac Imaging -- Coronary Calcium Scoring -- Cardiac CT Angiography -- Cardiac MRI Imaging. |
| Record Nr. | UNINA-9910337506103321 |
| Cham : , : Springer International Publishing : , : Imprint : Humana, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lipoproteins in Diabetes Mellitus / / edited by Alicia J. Jenkins, Peter P. Toth
| Lipoproteins in Diabetes Mellitus / / edited by Alicia J. Jenkins, Peter P. Toth |
| Autore | Jenkins Alicia J |
| Edizione | [2nd ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Humana, , 2023 |
| Descrizione fisica | 1 online resource (925 pages) |
| Disciplina | 612.01575 |
| Altri autori (Persone) | TothPeter P |
| Collana | Contemporary Diabetes |
| Soggetto topico |
Endocrinology
Blood-vessels - Diseases Cardiology Angiology |
| ISBN | 3-031-26681-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part 1 : Lipoprotein Metabolism, Qualitative Changes and Measurements -- 1. Laboratory Assessment of Lipoproteins in Type 2 Diabetes -- 2. Tools for Assessing Lipoprotein Metabolism in Diabetes Mellitus -- 3. Links Between Glucose and Lipoproteins -- 4. Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes -- 5. Lipoprotein metabolism and alterations induced by insulin resistance and diabetes -- 6. The PPAR system in diabetes -- 7. Production And Metabolism Of Triglyceride-Rich Lipoproteins: Impact Of Diabetes -- 8. Triglyceride- And Cholesterol-Rich Remnant Lipoproteins In Risk Of Cardiovascular Disease In Diabetes Mellitus -- 9. HDL Function In Diabetes -- 10. Lipoprotein (a): Metabolism, Pathophysiology and Impact on Diabetes Mellitus -- 11. Lipoprotein Glycation in Diabetes Mellitus -- 12. Lipid:Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes -- Part 2 : Lipoproteins and the Complications of Diabetes -- 13. The Role of Modified Forms of LDL and Corresponding Autoantibodies in the Development of Complications in Diabetes -- 14. Endothelial dysfunction in type 2 diabetes, with an update on new interventions -- 15. Lipoproteins and diabetic kidney disease -- 16. Lipids and Diabetic Retinopathy -- 17. Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy -- 18. The Role Of Lipids And Lipoproteins In Peripheral Neuropathy -- 19. Lipoproteins and Ischemic Stroke in Diabetes -- Part 3 : Lipoprotein Treatment in Diabetes -- 20. About Randomized Clinical Trials Related to Lipoproteins in Diabetes Mellitus -- 21. Effects of Lifestyle (Diet, Plant Sterols, Exercise and Smoking) and Glycemic Control on Lipoproteins in Diabetes -- 22. Statin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes -- 23. Statin intolerance – An overview for clinicians -- 24. Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes Mellitus Type 2 -- 25. EPA and Mixed Omega-3 Fatty Acids: Impact on Dyslipidemia and Cardiovascular Events in Patients With Diabetes -- 26. Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus -- 27. Clinical Efficacy Of Proprotein Convertase Synthase Kexin Type 9 Inhibition In Persons With Diabetes Mellitus -- 28. Clinical Care of Lipids in People with Type 1 diabetes -- 29. Adjunct drug treatment to reduce vascular disease in people with diabetes -- 30. Emerging lipoprotein-related therapeutics for patients with diabetes -- Part 4 : Epidemiology of Diabetes and Diabetic Dyslipidemia -- 31. Diabetes Epidemiology And Its Implications -- 32. Epidemiology, Control, and Cardiovascular Outcomes of Dyslipidemia in Diabetes. |
| Record Nr. | UNINA-9910731468903321 |
|
Jenkins Alicia J
|
||
| Cham : , : Springer International Publishing : , : Imprint : Humana, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lipoproteins in Diabetes Mellitus / / edited by Alicia J. Jenkins, Peter P. Toth, Timothy J. Lyons
| Lipoproteins in Diabetes Mellitus / / edited by Alicia J. Jenkins, Peter P. Toth, Timothy J. Lyons |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | New York, NY : , : Springer New York : , : Imprint : Humana, , 2014 |
| Descrizione fisica | 1 online resource (468 p.) |
| Disciplina |
616.4
616.4/62 616.462 |
| Collana | Contemporary Diabetes |
| Soggetto topico |
Endocrinology
Blood-vessels - Diseases Cardiology Angiology |
| ISBN | 1-4614-7554-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Laboratory Assessment of Lipoproteins in Diabetes -- Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin Resistance Diabetes -- Insulin Resistance and Atherosclerosis -- Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes -- Lipoprotein Metabolism and Alterations induced by insulin resistance and diabetes -- Production and Metabolism of Triglyceride-Rich Lipoproteins in both the Normal and Diabetic States -- Lipoprotein(a): Structure, Metabolism and Pathophysiology -- Lipoprotein Glycation in Diabetes Mellitus.-Lipoprotein (LDL and HDL) Oxidation in Diabetes Mellitus -- The Role of Modified Forms of LDL and Corresponding Autoantibodies in the Development of Complications in Diabetes -- Lipid – Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes -- Tools for Assessing Lipoprotein Metabolism in Diabetes Mellitus -- Endothelial Dysfunction and Dyslipidaemia in Type 2 Diabetes: Pathogenesis, Significance and Therapy -- Lipoproteins and Diabetic Nephropathy -- Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy -- Effects of Lifestyle (Diet, Plant Sterols, Excercise) and Glycemic Control on Lipoporteins in Diabetes -- About Randomised Clinical Trials Related to Lipoproteins in Diabetes Mellitus -- Statin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients -- The PPAR System in Diabetes -- Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients -- Niacin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients -- Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus -- Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes. |
| Record Nr. | UNINA-9910300088703321 |
| New York, NY : , : Springer New York : , : Imprint : Humana, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||